scispace - formally typeset
I

Imran Masood

Researcher at Islamia University

Publications -  53
Citations -  944

Imran Masood is an academic researcher from Islamia University. The author has contributed to research in topics: Medicine & Glaucoma. The author has an hindex of 14, co-authored 42 publications receiving 750 citations. Previous affiliations of Imran Masood include Birmingham City Hospital & King Saud University.

Papers
More filters
Journal ArticleDOI

The role of pharmacists in developing countries: the current scenario in Pakistan

TL;DR: Although the pharmacy profession in Pakistan is continuously evolving, the health care system of Pakistan has yet to recognize the pharmacist's role, and this lack of recognition is due to the limited interaction of pharmacists with the public.
Journal ArticleDOI

The PharmD degree in developing countries.

TL;DR: It is imperative to evaluate the state of pharmacy education in India before fully supporting this decision to introduce PharmD (post-bacclaureate degree) courses, and according to the International Pharmaceutical Federation, there must be well-planned execution of good pharmacy practice in developing countries.
Journal ArticleDOI

Pattern of medication selling and self-medication practices: A study from Punjab, Pakistan.

TL;DR: Many types of medicines were often sold without prescription from community pharmacies in Punjab, Pakistan, and self-medication was common practice for a wide range of illnesses.

Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study

TL;DR: Although good perception and attitude were noted among the respondents, dissemination of information regarding generic medicines may perhaps strengthen generic prescribing, and there is a need to introduce ‘Quality by Design’ concept in local manufacturing units.
Journal ArticleDOI

Prospective Evaluation of Two iStent ® Trabecular Stents, One iStent Supra ® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes

TL;DR: IOP control was achieved safely with two trabecular micro-bypass stents, one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open angle glaucoma, and this microinvasive, ab interno approach introduces a possible new treatment option forRefractory disease.